A clinical trial to assess the immunogenicity and safety of Inactivated Influenza Vaccine (Whole Virion) IP (Pandemic Influenza (H1N1) 2009 Monovalent Vaccine; VaxiFlu-STM) in healthy Indian adult population
Author(s) -
AH Kubavat,
Ravindra Mittal,
PM Patel,
DH Jarsaniya,
P. G. Pawar .
Publication year - 2011
Publication title -
journal of postgraduate medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.405
H-Index - 52
eISSN - 0972-2823
pISSN - 0022-3859
DOI - 10.4103/0022-3859.81860
Subject(s) - medicine , seroconversion , immunogenicity , vaccination , titer , population , hemagglutinin (influenza) , hemagglutination assay , influenza vaccine , virology , confidence interval , immunology , antibody , environmental health
The pandemic of H1N1 2009 influenza has spread world over and low degree of virus transmission has continued in several regions of India.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom